• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA. EPIC STENTED TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA. EPIC STENTED TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Endocarditis (1834); Hemolysis (1886); Renal Failure (2041); Thromboembolism (2654); Mitral Valve Insufficiency/ Regurgitation (4451)
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
Related manufacturing reference number 3001883144-2021-00088.An article "durability of mitral valve replacement with a 3rd generation bioprosthesis", was reviewed.This research article is a retrospective single center experience to evaluate the durability of a third-generation porcine bioprosthesis (epic valve) in the mitral position, according to patients¿ age at surgery.Epic valve (abbott) was associated with the study.The article concluded the epic bioprosthesis showed good durability at 5 to 10 years in the mitral position.The primary and correspondence author of the article is amedeo anselmi, md, phd, division of thoracic and cardiovascular surgery, pontchaillou university hospital, 2 rue henri le guilloux, 35000 rennes, france , with the email amedeo.Anselmi@chu-rennes.Fr.
 
Manufacturer Narrative
As reported in a research article, 482 patients underwent mitral valve replacement using an epic valve between 2009 and 2018.Events of stroke, renal failure, reoperation, nonstructural valve dysfunction, structural valve dysfunction, endocarditis, regurgitation, hemolysis, thromboembolic events, perivalvular leak, and global left atrial thrombosis were reported.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC STENTED TISSUE VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA.
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
MDR Report Key11967217
MDR Text Key255155423
Report Number3001883144-2021-00087
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 06/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
-
-